Patent · US Expired

Antipyretic and analgesic methods of using optically pure R-etodolac

US5561151A · kind A · utility

14Cited by

9References

16Claims

0Family size

Assignee

Sepracor, Inc. · US

Inventors

James W. Young · Palo Alto, US
Nancy M. Gray · Ellisville, US
William J. Wechter · Redlands, US

Key dates

Filing date	Jan 4, 1995
Grant date	Oct 1, 1996
Priority date	—
Expiry date	Jan 4, 2015

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods are disclosed utilizing optically pure R(-) etodolac for the treatment of pain, including but not limited to pain associated with toothaches, headaches, sprains, joint pain and surgical pain, for example dental pain and ophthalmic pain, while substantially reducing adverse effects which are associated with the administration of the racemic mixture of etodolac. The optically pure R(-) etodolac is also useful in treating pyrexia while substantially reducing the adverse effects associated with the administration of the racemic mixture of etodolac.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.